Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.

Choi, Sung R., Howell, Owain W., Carassiti, Daniele, Magliozzi, Roberta, Gveric, Djordje, Muraro, Paolo A., Nicholas, Richard, Roncaroli, Federico +1 more·2012·Brain

DOI 10.1093/brain/aws189

Cited by (385)

Items 101–200 of 385

Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology
Gabriele Carmine DeLuca, Rose Alterman, Jenny L. Martin, Arunesh Mittal, Samkeliso V. Blundell, Shannon Bird, Harry Beale, Lai San Hong, Margaret M. Esiri · 2013 · Brain
Stem Cell Therapies for Progressive Multiple Sclerosis
Jayden A. Smith, Alexandra M. Nicaise, Rosana-Bristena Ionescu, Regan Hamel, Luca Peruzzotti‐Jametti, Stefano Pluchino · 2021 · Frontiers in Cell and Developmental Biology
Neuropathology of Multiple Sclerosis
Bogdan F. Gh. Popescu, Claudia Francesca Lucchinetti · 2015 · Elsevier eBooks
Meningeal and choroid plexus cells—Novel drug targets for CNS disorders
Mike Dragunow · 2013 · Brain Research
No association between cortical lesions and leptomeningeal enhancement on 7-Tesla MRI in multiple sclerosis
Mehrnaz Ighani, Samuel N. Jonas, I. Izbudak, Seongjin Choi, Alfonso Lema-Dopico, J. Hua, E. O'Connor, D. Harrison · 2019 · Multiple Sclerosis
Cortical lesions in multiple sclerosis: inflammation versus neurodegeneration
Hans Lassmann · 2012 · Brain
Ectopic lymphoid follicles in progressive multiple sclerosis: From patients to animal models
Zhan, Jiangshan, Kipp, Markus, Han, Wenling, Kaddatz, Hannes · 2021 · Immunology
B cell follicle-like structures in multiple sclerosis—With focus on the role of B cell activating factor
Morten Haugen, Jette Lautrup Frederiksen, Matilda Degn · 2014 · Journal of Neuroimmunology
Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Postcontrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis
Robert Zivadinov, Deepa Preeti Ramasamy, Jesper Hagemeier, Channa Kolb, Niels Bergsland, Ferdinand Schweser, Michael G. Dwyer, Bianca Weinstock‐Guttman, David W. Hojnacki · 2018 · American Journal of Neuroradiology
Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis
Mario Stampanoni Bassi, Antonietta Gentile, Ennio Iezzi, Sara Zagaglia, Alessandra Musella, Ilaria Simonelli, Luana Gilio, Roberto Furlan, Annamaria Finardi, Girolama Alessandra Marfia et al. · 2019 · Frontiers in Neurology
Structural and functional conservation of non-lumenized lymphatic endothelial cells in the mammalian leptomeninges
Shannon Shibata-Germanos, James R. Goodman, Alan Greig, Chintan A. Trivedi, Bridget C. Benson, Sandrine C. Foti, Ana Faro, Raphaël F. P. Castellan, Rosa Maria Correra, Melissa Barber et al. · 2019 · Acta Neuropathologica
An “Outside-In” and “Inside-Out” Consideration of Complement in the Multiple Sclerosis Brain: Lessons From Development and Neurodegenerative Diseases
B. Paul Morgan, Jennifer L. Gommerman, Valeria Ramaglia · 2021 · Frontiers in Cellular Neuroscience
Ectopic Lymphoid Follicles in Multiple Sclerosis: Centers for Disease Control?
Negron, Austin, Stüve, Olaf, Forsthuber, Thomas G. · 2020 · Frontiers in Neurology
BAFF is decreased in the cerebrospinal fluid of multiple sclerosis at clinical onset
Marco Puthenparampil, Silvia Miante, Lisa Federle, Chiara Zanetta, Elisabetta Toffanin, Susanna Ruggero, Francesca Rinaldi, Paolo Gallo · 2016 · Journal of Neuroimmunology
Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects
Anna J. Khalaj, Jonathan Hasselmann, Catherine J. Augello, Spencer M. Moore, Seema Kaushalya Tiwari-Woodruff · 2016 · The Journal of Steroid Biochemistry and Molecular Biology
Anti-CD20 monoclonal antibodies in multiple sclerosis
Irene Moreno‐Torres, Antonio García‐Merino · 2016 · Expert Review of Neurotherapeutics
Cerebrospinal fluid biomarkers link toxic astrogliosis and microglial activation to multiple sclerosis severity
Ruturaj Masvekar, Tianxia Wu, Peter F. Kosa, Christopher R. Barbour, Valentina Fossati, Bibiana Bielekova · 2018 · Multiple Sclerosis and Related Disorders
Bruton’s tyrosine kinase inhibition in multiple sclerosis
Schneider, Raphael, Oh, Jiwon · 2022 · Current Neurology and Neuroscience Reports
Correction: Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
Jeppe Romme Christensen, Lars Svend Börnsen, Rikke Lenhard Ratzer, Fredrik Piehl, Mohsen Khademi, Tomas P Olsson, Per Soelberg SÃ ̧rensen, Finn Thorup Sellebjerg · 2013 · PLoS ONE
Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally
Anders Svenningsson, Joakim Bergman, Ann M. Dring, Mattias Vågberg, Richard Birgander, Thomas Lindqvist, Jonathan D. Gilthorpe, Tommy A. Bergenheim · 2015 · Neurology Neuroimmunology & Neuroinflammation
Periventricular lesions correlate with cortical thinning in multiple sclerosis
Margit Jehna, Lukas Pirpamer, Michael Khalil, Siegrid Fuchs, Stefan Ropele, Christian Langkammer, Alexander Pichler, Franziska Stulnig, Hannes Deutschmann, Franz Fazekas et al. · 2015 · Annals of Neurology
Leptomeningeal Contrast Enhancement Is Related to Focal Cortical Thinning in Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional MRI Study
Niels Bergsland, Deepa Preeti Ramasamy, Eleonora Tavazzi, David W. Hojnacki, Bianca Weinstock‐Guttman, Robert Zivadinov · 2019 · American Journal of Neuroradiology
Inversion Recovery Susceptibility Weighted Imaging With Enhanced T2 Weighting at 3 T Improves Visualization of Subpial Cortical Multiple Sclerosis Lesions
Erin Beck, Neville Gai, Stefano Filippini, Josefina Maranzano, Govind Nair, Daniel S. Reich · 2020 · Investigative Radiology
Myelin Repair: From Animal Models to Humans
Myriam Cayre, Marie Falque, Océane Mercier, Karine Magalon, Pascale Durbec · 2021 · Frontiers in Cellular Neuroscience
Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis
Serena Ruggieri, Maria Petracca, Aaron Miller, Stephen C. Krieger, Rezwan Ghassemi, Yadira Bencosme, Claire Riley, Jonathan Howard, FRED D. LUBLIN, Matilde Inglese · 2015 · JAMA Neurology
Gray Matter Pathology in MS: Neuroimaging and Clinical Correlations
Justin Morris Honce · 2013 · Multiple Sclerosis International
A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives
Emanuele D’Amico, Francesco Patti, Aurora Zanghì, Mario Zappia · 2016 · International Journal of Molecular Sciences
Imaging cortical multiple sclerosis lesions with ultra-high field MRI
Mads Alexander Just Madsen, Vanessa Wiggermann, Stephan Bramow, Jeppe Romme Christensen, Finn Thorup Sellebjerg, Hartwig Roman Siebner · 2021 · NeuroImage Clinical
Leptomeningeal inflammation in multiple sclerosis: Insights from animal and human studies
Cassie Wicken, James V. Nguyen, Rahul Karna, Pavan Bhargava · 2018 · Multiple Sclerosis and Related Disorders
Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients
Marloes Prins, Ranjan Dutta, Bart M. L. Baselmans, John J. P. Brevé, John G. J. M. Bol, Sadie A. Deckard, Paul van der Valk, Sandra Amor, Bruce D. Trapp, Helga E. de Vries et al. · 2014 · Acta Neuropathologica Communications
Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelination
Rodriguez, Enrique Garea, Wegner, Christiane, Kreutzfeldt, Mario, Neid, Katharina, Thal, Dietmar R., Jürgens, Tanja, Brück, Wolfgang, Stadelmann, Christine, Merkler, Doron · 2014 · Acta Neuropathologica
Longitudinal Persistence of Meningeal Enhancement on Postcontrast 7T 3D-FLAIR MRI in Multiple Sclerosis
Samuel N. Jonas, Izlem Izbudak, Aletta Ann Frazier, Daniel M. Harrison · 2018 · American Journal of Neuroradiology
Multiple sclerosis: Immunopathological heterogeneity and its implications
Britta Engelhardt, Manuel Comabella, Andrew Chan · 2022 · European Journal of Immunology
Temporal lobe cortical pathology and inhibitory GABA interneuron cell loss are associated with seizures in multiple sclerosis
R. Nicholas, R. Magliozzi, Graham R. Campbell, Don H. Mahad, R. Reynolds · 2016 · Multiple Sclerosis
White and gray matter damage in primary progressive MS
Benedetta Bodini, Declan Chard, Daniel R. Altmann, Daniel J. Tozer, David H. Miller, Alan J. Thompson, Claudia A. M. Gandini Wheeler‐Kingshott, Olga Ciccarelli · 2015 · Neurology
CSF Levels of CXCL12 and Osteopontin as Early Markers of Primary Progressive Multiple Sclerosis
Damiano Marastoni, Roberta Magliozzi, Anna Bolzan, Anna Isabella Pisani, Stefania Rossi, Francesco Crescenzo, Stefania Montemezzi, Francesca Benedetta Pizzini, Massimiliano Calabrese · 2021 · Neurology Neuroimmunology & Neuroinflammation
IL-10-providing B cells govern pro-inflammatory activity of macrophages and microglia in CNS autoimmunity
Anastasia Geladaris, Silke Häusser‐Kinzel, Roxanne Pretzsch, Nitzan Nissimov, Klaus Lehmann‐Horn, Darius Häusler, Martin S. Weber · 2023 · Acta Neuropathologica
Tertiary Lymphoid Structures in the Central Nervous System: Implications for Glioblastoma
Tiarne van de Walle, Alessandra Vaccaro, Mohanraj Ramachandran, Ilkka Pietilä, Magnus Essand, Anna Dimberg · 2021 · Frontiers in Immunology
Contribution of B cells to cortical damage in multiple sclerosis
Pavan Bhargava, Hans-Peter Hartung, Peter A. Calabresi · 2022 · Brain
Cerebrospinal fluid proteomics in multiple sclerosis
Ann Cathrine Kroksveen, Jill Anette Opsahl, Astrid Guldbrandsen, Kjell‐Morten Myhr, Eystein Oveland, Øivind Torkildsen, Frode S. Berven · 2014 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Impact of Glatiramer Acetate on B Cell-Mediated Pathogenesis of Multiple Sclerosis
Stefanie Küerten, Leila J. Jackson, Joel Kaye, Timothy L. Vollmer · 2018 · CNS Drugs
MRI in multiple sclerosis: what is changing?
Massimo Filippi, Paolo Preziosa, Maria Assunta Rocca · 2018 · Current Opinion in Neurology
Siponimod therapy implicates Th17 cells in a preclinical model of subpial cortical injury
Lesley A. Ward, Dennis S. W. Lee, Anshu Kumar Sharma, Angela A. Wang, Ikbel Naouar, I. Xianjie, Natalia Barbara Pikor, Barbara Nuesslein‐Hildesheim, Valeria Ramaglia, Jennifer L. Gommerman · 2019 · JCI Insight
Cellular senescence and failure of myelin repair in multiple sclerosis
Paraskevi N. Koutsoudaki, Dimitrios Papadopoulos, Panagiotis-Georgios Passias, Pinelopi Koutsoudaki, Vassilis G. Gorgoulis · 2020 · Mechanisms of Ageing and Development
Absence of B Cells in Brainstem and White Matter Lesions Associates With Less Severe Disease and Absence of Oligoclonal Bands in MS
Nina L. Fransen, Brigit A. de Jong, Katharina Heß, Tanja Kuhlmann, Maria C. J. Vincenten, Jörg Hamann, Inge Huitinga, Joost Smolders · 2021 · Neurology Neuroimmunology & Neuroinflammation
Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases
Aigli G. Vakrakou, Maria-Evgenia Brinia, Ioanna P. Svolaki, Theodore Argyrakos, Leonidas Stefanis, Constantinos Kilidireas · 2022 · Frontiers in Neurology
Gene expression analysis of relapsing–remitting, primary progressive and secondary progressive multiple sclerosis
Rikke Lenhard Ratzer, Helle Bach Søndergaard, Jeppe Romme Christensen, Lars Svend Börnsen, Rehannah Borup, Per Soelberg Sørensen, Finn Thorup Sellebjerg · 2013 · Multiple Sclerosis Journal
The Multiple Roles of B Cells in Multiple Sclerosis and Their Implications in Multiple Sclerosis Therapies
Rui Li, Amit Bar‐Or · 2018 · Cold Spring Harbor Perspectives in Medicine
Progressive Multiple Sclerosis
Daniel Ontaneda · 2019 · CONTINUUM Lifelong Learning in Neurology
Mechanisms underlying lesion development and lesion distribution in CNS autoimmunity
Maren Lindner, Luisa Klotz, Heinz Wiendl · 2018 · Journal of Neurochemistry
Widespread cortical demyelination of both hemispheres can be induced by injection of pro‐inflammatory cytokines via an implanted catheter in the cortex of MOG‐immunized rats
M. Üçal, M. Haindl, Milena Z. Adzemovic, Johannes Strasser, Lisa Theisl, Manuel Zeitelhofer, Klaus Kraitsy, S. Ropele, U. Schäfer, F. Fazekas et al. · 2017 · Experimental Neurology
Ocrelizumab: a B-cell depleting therapy for multiple sclerosis
Dejan Jakimovski, Bianca Weinstock‐Guttman, Murali Krishna Ramanathan, Channa Kolb, David W. Hojnacki, Alireza Minagar, Robert Zivadinov · 2017 · Expert Opinion on Biological Therapy
A new focal model resembling features of cortical pathology of the progressive forms of multiple sclerosis: Influence of innate immunity
Berenice Anabel Silva, María Celeste Leal, María Isabel Farías, Juan Carlos Ávalos, Cristina Hilda Besada, Fernando Juan Pitossi, Carina Cintia Ferrari · 2018 · Brain Behavior and Immunity
Regulation of neuroinflammation by B cells and plasma cells
Angela A. Wang, Olga L. Rojas, Dennis S. W. Lee, Jennifer L. Gommerman · 2020 · Immunological Reviews
Disorders of vision in multiple sclerosis
Roshan Dhanapalaratnam, Maria Panayiota Markoulli, Arun V. Krishnan · 2021 · Clinical and Experimental Optometry
Magnetic Resonance Imaging in Primary Progressive Multiple Sclerosis Patients
Małgorzata Siger · 2022 · Clinical Neuroradiology
Synapse Dysfunctions in Multiple Sclerosis
Karin Schwarz, Frank Schmitz · 2023 · International Journal of Molecular Sciences
Peripheral B cell depletion and central proinflammatory cytokine reduction following repeated intrathecal administration of rituximab in progressive Multiple Sclerosis
Valeria Studer, Silvia Rossi, Caterina Motta, Fabio Buttari, Diego Centonze · 2014 · Journal of Neuroimmunology
A Review of Compartmentalised Inflammation and Tertiary Lymphoid Structures in the Pathophysiology of Multiple Sclerosis
Rachael Kee, Michelle Naughton, Gavin V McDonnell, Owain W. Howell, Denise C. Fitzgerald · 2022 · Biomedicines
Peripheral imbalanced TFH/TFR ratio correlates with intrathecal IgG synthesis in multiple sclerosis at clinical onset
Marco Puthenparampil, Antonio Zito, Giorgia Pantano, Lisa Federle, Erica Stropparo, Silvia Miante, Giustina De Silvestro, Mario Plebani, Paolo Gallo · 2018 · Multiple Sclerosis Journal
Novel MRI and PET markers of neuroinflammation in multiple sclerosis
Marloes H. J. Hagens, Bart N.M. van Berckel, Frederik Barkhof · 2016 · Current Opinion in Neurology
Multiple Sclerosis Re-Examined: Essential and Emerging Clinical Concepts
Jonathan D. Zurawski, James M. Stankiewicz · 2017 · The American Journal of Medicine
Anti-CD20 Depletes Meningeal B Cells but Does Not Halt the Formation of Meningeal Ectopic Lymphoid Tissue
Rosa Margareta Brand, Verena Friedrich, Jolien Diddens, Monika Pfaller, Francesca Romana de Franchis, Helena Radbruch, Bernhard Hemmer, Katja Steiger, Klaus Lehmann‐Horn · 2021 · Neurology Neuroimmunology & Neuroinflammation
New Prospects for Ultra-High-Field Magnetic Resonance Imaging in Multiple Sclerosis
Benjamin Victor Ineichen, Erin Beck, Marco Piccirelli, Daniel S. Reich · 2021 · Investigative Radiology
Ocrelizumab for the treatment of multiple sclerosis
Kévin Bigaut, Jerome De Seze, Nicolas Collongues · 2018 · Expert Review of Neurotherapeutics
Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of Progressive Multiple Sclerosis
DiSano, Krista D., Royce, Darlene B., Gilli, Francesca, Pachner, Andrew R. · 2019 · Frontiers in Immunology
Modulation of host immune responses following non-hematopoietic stem cell transplantation: Translational implications in progressive multiple sclerosis
Giulio Volpe, Joshua D. Bernstock, Luca Peruzzotti‐Jametti, Stefano Pluchino · 2016 · Journal of Neuroimmunology
Ocrelizumab treatment in multiple sclerosis: A Danish population‐based cohort study
Luigi Pontieri, Morten Blinkenberg, Stephan Bramow, Viktoria Papp, Peter Vestergaard Rasmussen, Matthias Kant, Jakob Schäfer, Henrik Kahr Mathiesen, Michael Broksgaard Jensen, Georgi P. Sirakov et al. · 2021 · European Journal of Neurology
Cerebellar volume as imaging outcome in progressive multiple sclerosis
Matilde Inglese, Maria Petracca, Enricomaria Mormina, Anat Achiron, Rebecca Straus-Farber, Shmuel Miron, Michelle T. Fabian, Stephen C. Krieger, Aaron Miller, FRED D. LUBLIN et al. · 2017 · PLoS ONE
Primary progressive multiple sclerosis: current therapeutic strategies and future perspectives
Alberto Gajofatto, Marco Turatti, Maria Donata Benedetti · 2016 · Expert Review of Neurotherapeutics
Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study
David H. Miller, FRED D. LUBLIN, Maria Pia Sormani, Ludwig Kappos, Özgür Yaldizli, Mark S. Freedman, Bruce Cree, Howard L. Weiner, Catherine Lubetzki, Hans‐Peter Hartung et al. · 2018 · Annals of Clinical and Translational Neurology
Characterization of leptomeningeal inflammation in rodent experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis
Suyog U. Pol, Ferdinand Schweser, Nicola Bertolino, Marilena Preda, Michele Sveinsson, Michelle L. Sudyn, Natan Babek, Robert Zivadinov · 2019 · Experimental Neurology
Update on pathology of central nervous system inflammatory demyelinating diseases
Alicja Kalinowska, Yong Guo, Claudia Francesca Lucchinetti · 2022 · Neurologia i Neurochirurgia Polska
CNS Resident Innate Immune Cells: Guardians of CNS Homeostasis
Luca Muzio, Jessica Perego · 2024 · International Journal of Molecular Sciences
The Role of B Cells in Primary Progressive Multiple Sclerosis
Jameson P. Holloman, Robert C. Axtell, Nancy L. Monson, Gregory F. Wu · 2021 · Frontiers in Neurology
Ocrelizumab effect on humoral and cellular immunity in multiple sclerosis and its clinical correlates: a 3-year observational study
Nicola Capasso, Raffaele Palladino, Vincenza Cerbone, Antonio Luca Spiezia, Bianca Covelli, Antonia Fiore, Roberta Lanzillo, Antonio Carotenuto, Maria Petracca, Lucia Stanziola et al. · 2022 · Journal of Neurology
Multiple Sclerosis CSF Is Enriched With Follicular T Cells Displaying a Th1/Eomes Signature
J. Morille, Marion Mandon, Stéphane Rodriguez, David Roulois, Simon Léonard, Alexandra Garcia, Sandrine Wiertlewski, Emmanuelle Le Page, Laureline Berthelot, Arnaud B. Nicot et al. · 2022 · Neurology Neuroimmunology & Neuroinflammation
Intrathecal CD8 + CD20 + T Cells in Primary Progressive Multiple Sclerosis
Marina Rode von Essen, Jacob Talbot, Rikke Holm Hansen, Helene Højsgaard Chow, Henrik Lundell, Hartwig Roman Siebner, Finn Thorup Sellebjerg · 2023 · Neurology Neuroimmunology & Neuroinflammation
Immunopathology of Japanese macaque encephalomyelitis is similar to multiple sclerosis
Tiffany C. Blair, Minsha Manoharan, Stephanie D. Rawlings-Rhea, Ian Tagge, Steven G. Kohama, Julie A. Hollister‐Smith, Betsy M. Ferguson, Randall L. Woltjer, Meredith C. Frederick, James Pollaro et al. · 2015 · Journal of Neuroimmunology
New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond
Joseph J. Sabatino, Bruce Cree, Stephen L. Hauser · 2025 · Annals of Neurology
The Potential Contribution of Dysfunctional RNA-Binding Proteins to the Pathogenesis of Neurodegeneration in Multiple Sclerosis and Relevant Models
Cole D. Libner, Hannah E. Salapa, Michael C. Levin · 2020 · International Journal of Molecular Sciences
A B Cell-Driven Autoimmune Pathway Leading to Pathological Hallmarks of Progressive Multiple Sclerosis in the Marmoset Experimental Autoimmune Encephalomyelitis Model
Bert A. ‘t Hart, Jordon Dunham, Bart W. Faber, Jon D. Laman, Jack van Horssen, Jan Bauer, Yolanda S. Kap · 2017 · Frontiers in Immunology
B Cells in the CNS at Postmortem Are Associated With Worse Outcome and Cell Types in Multiple Sclerosis
Marcello Moccia, Lukas Haider, Arman Eshaghi, Steven H. van de Pavert, Vincenzo Brescia Morra, Amy Patel, Claudia A. M. Gandini Wheeler‐Kingshott, Frederik Barkhof, Olga Ciccarelli · 2021 · Neurology Neuroimmunology & Neuroinflammation
Complement activation and increased anaphylatoxin receptor expression are associated with cortical grey matter lesions and the compartmentalised inflammatory response of multiple sclerosis
Rhian Evans, Lewis M. Watkins, Kristen Hawkins, Gabriella Santiago, Constantinos Demetriou, Michelle Naughton, Marie Dittmer, Mark I. Rees, Denise C. Fitzgerald, B. Paul Morgan et al. · 2023 · Frontiers in Cellular Neuroscience
Characterization of cortico-meningeal translocator protein expression in multiple sclerosis
Elena Herranz, Constantina A. Treaba, Valeria Teresa Barletta, Ambica Mehndiratta, Russell Ouellette, Jacob A. Sloane, Carolina Ionete, Suma Babu, Marina Mastantuono, Stefano Magon et al. · 2024 · Brain
Increased Meningeal T and Plasma Cell Infiltration is Associated with Early Subpial Cortical Demyelination in Common Marmosets with Experimental Autoimmune Encephalomyelitis
Nadine Kramann, Katharina Neid, Lena Menken, Christina Schlumbohm, Christine Stadelmann, Eberhard Fuchs, Wolfgang Brück, Christiane Wegner · 2014 · Brain Pathology
Cortical lesion load correlates with diffuse injury of multiple sclerosis normal appearing white matter
N. Mistry, R. Abdel-Fahim, O. Mougin, C. Tench, P. Gowland, N. Evangelou · 2014 · Multiple Sclerosis
Do All Patients with Multiple Sclerosis Benefit from the Use of Contrast on Serial Follow-Up MR Imaging? A Retrospective Analysis
Raghav R. Mattay, K. Davtyan, Michel Bilello, Alexander C. Mamourian · 2018 · American Journal of Neuroradiology
Intrathecal Rituximab Therapy in Multiple Sclerosis: Review of Evidence Supporting the Need for Future Trials
Mickaël Bonnan, Sylvie Ferrari, Eric Bertandeau, Stéphanie Demasles, Elsa Krim, Marie Miquel, Bruno Thierry Barroso · 2014 · Current Drug Targets
An update on the role of magnetic resonance imaging in predicting and monitoring multiple sclerosis progression
Piriyankan Ananthavarathan, Nitin Sahi, Declan Chard · 2024 · Expert Review of Neurotherapeutics
Magnetisation transfer ratio abnormalities in primary and secondary progressive multiple sclerosis
James William L Brown, Azmain Chowdhury, Baris Kanber, Ferrán Prados, Arman Eshaghi, Carole H. Sudre, Matteo Pardini, Rebecca S. Samson, Steven H. van de Pavert, Claudia A. M. Gandini Wheeler‐Kingshott et al. · 2019 · Multiple Sclerosis Journal
Features of ectopic lymphoid-like structures in human uveitis
Simon J. Epps, Natalie Coplin, Philip J. Luthert, Andrew D. Dick, Sarah E. Coupland, Lindsay B. Nicholson · 2019 · Experimental Eye Research
Stromal Cell–Mediated Coordination of Immune Cell Recruitment, Retention, and Function in Brain-Adjacent Regions
Valeria Ramaglia, Alexandra Florescu, Michelle Zuo, Salma Sheikh‐Mohamed, Jennifer L. Gommerman · 2021 · The Journal of Immunology
An optimized animal model of lysolecithin induced demyelination in optic nerve; more feasible, more reproducible, promising for studying the progressive forms of multiple sclerosis
Dehghan, Samaneh, Aref, Ehsan, Raoufy, Mohammad Reza, Javan, Mohammad · 2021 · Journal of Neuroscience Methods
The use of 7T MRI in multiple sclerosis: review and consensus statement from the North American Imaging in Multiple Sclerosis Cooperative
Daniel M. Harrison, Pascal Sati, Eric C. Klawiter, Sridar Narayanan, Francesca R. Bagnato, Erin Beck, Peter B. Barker, Alberto Calvi, Alessandro Cagol, Maxime Donadieu et al. · 2024 · Brain Communications
Acute disseminated encephalomyelitis and other inflammatory demyelinating variants
Neil J. Scolding · 2014 · Handbook of clinical neurology
A novel imaging marker of cortical “cellularity” in multiple sclerosis patients
Muhamed Baraković, Matthias Weigel, Alessandro Cagol, Sabine A. Schaedelin, Riccardo Galbusera, Po‐Jui Lu, Xinjie Chen, Lester Melie‐García, Mario Ocampo‐Pineda, Erik Bahn et al. · 2024 · Scientific Reports
Perivascular tissue resident memory T cells as therapeutic target in multiple sclerosis
Joost Smolders, Nina L. Fransen, Cheng‐Chih Hsiao, Jörg Hamann, Inge Huitinga · 2020 · Expert Review of Neurotherapeutics
B Cells in Multiple Sclerosis and Virus-Induced Neuroinflammation
Rittika Chunder, Verena Schropp, Stefanie Küerten · 2020 · Frontiers in Neurology
Relapsing–remitting and primary progressive MS have the same cause(s)- the neuropathologist’s view: 2
Tanja Kuhlmann · 2013 · Multiple Sclerosis Journal